Cosmo Pharmaceuticals S.p.A Stock Swiss Exchange
Stocks
IT0004167463
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Swiss Exchange
|
||
| - CHF | - |
|
| 08-28 | Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation | RE |
| 08-14 | Cosmo Pharmaceuticals to Adopt New Ticker on SIX Swiss Exchange | MT |
| Market Cap | 1.01B 1.17B 950M 866M 1.62B 110B 1.63B 11.25B 4.37B 56.48B 4.39B 4.29B 186B | P/E 2026 * |
873x | P/E 2027 * | 20.3x |
|---|---|---|---|---|---|
| Enterprise Value | 980M 1.14B 923M 841M 1.57B 107B 1.58B 10.93B 4.24B 54.88B 4.27B 4.17B 180B | EV / Sales 2026 * |
9.22x | EV / Sales 2027 * | 5.57x |
| Free-Float |
40.52% | Yield 2026 * |
3.62% | Yield 2027 * | 3.85% |
Last Transcript : Cosmo Pharmaceuticals S.p.A
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 24/05/2024 | |
| Director of Finance/CFO | - | 11/11/2024 | |
Paolo Lanzarotti
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/01/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Mauro Ajani
CHM | Chairman | 71 | 01/01/2014 |
| Director/Board Member | 71 | 01/04/2012 | |
Niall Donnelly
BRD | Director/Board Member | 54 | 24/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.26% | -2.19% | +58.24% | +108.42% | 1,034B | |
| +1.31% | +1.78% | +54.34% | +71.03% | 654B | |
| +0.15% | -1.16% | +22.62% | +77.86% | 459B | |
| +0.49% | -5.19% | +33.28% | +35.53% | 343B | |
| +0.27% | +3.26% | +29.76% | +47.50% | 307B | |
| +0.12% | -2.11% | +0.60% | +12.03% | 251B | |
| +0.48% | -0.23% | +53.11% | +72.95% | 237B | |
| +2.64% | -1.08% | -15.85% | -53.97% | 202B | |
| -0.14% | +1.06% | +32.78% | +99.12% | 186B | |
| Average | +0.60% | -2.88% | +29.88% | +52.27% | 407.95B | |
| Weighted average by Cap. | +0.54% | -3.31% | +38.75% | +67.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 106M 123M 100M 91.23M 171M 11.64B 172M 1.19B 460M 5.95B 463M 453M 19.55B | 176M 204M 166M 151M 282M 19.27B 284M 1.96B 762M 9.85B 766M 749M 32.37B |
| Net income | 1.27M 1.48M 1.2M 1.09M 2.04M 140M 2.06M 14.22M 5.52M 71.36M 5.55M 5.43M 234M | 49.6M 57.5M 46.73M 42.57M 79.57M 5.43B 80.17M 553M 215M 2.78B 216M 211M 9.12B |
| Net Debt | -28.5M -33.03M -26.85M -24.46M -45.72M -3.12B -46.06M -318M -123M -1.6B -124M -121M -5.24B | -28.81M -33.39M -27.13M -24.72M -46.21M -3.15B -46.56M -321M -125M -1.61B -125M -123M -5.3B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
